FA2H

F-75 Therapeutic Milk

Classification
External resources

{{This medical treatment related article is a stub. You can help WikiMD by expanding it.}}

F-75 is a therapeutic milk formula used in the initial phase of treatment for children suffering from severe acute malnutrition (SAM). It is specifically designed to provide essential nutrients in a form that is easily digestible and absorbed by the body, which is crucial for malnourished children who may have compromised digestive systems.

Composition

F-75 is formulated to provide 75 kilocalories per 100 milliliters, hence the name. The composition of F-75 is carefully balanced to ensure that it meets the nutritional needs of malnourished children without overwhelming their fragile systems. The main components include:

• Skimmed milk powder
• Sugar
• Vegetable oil
• Electrolytes (such as potassium and magnesium)
• Vitamins (such as vitamin A, D, E, and K)
• Minerals (such as zinc and copper)

The formula is low in protein and sodium to prevent refeeding syndrome, a potentially fatal condition that can occur when feeding is restarted in severely malnourished individuals.

Indications

F-75 is indicated for the initial stabilization phase of treatment in children with severe acute malnutrition. This phase typically lasts for 2-7 days, during which the child's metabolic functions are stabilized, and any infections or complications are treated. F-75 is not intended for long-term use or for children who are not severely malnourished.

Administration

F-75 is administered orally, and the amount given is based on the child's weight. It is typically given every two to three hours, with the volume gradually increased as the child tolerates it. The goal is to provide enough energy and nutrients to stabilize the child without causing metabolic complications.

Transition to F-100

Once the child is stabilized and can tolerate more nutrients, they are transitioned to F-100, another therapeutic milk formula with a higher energy and protein content. F-100 is used in the rehabilitation phase of treatment to promote catch-up growth.

Clinical Considerations

Healthcare providers must monitor children closely during the administration of F-75. Key considerations include:

• Monitoring for signs of refeeding syndrome
• Ensuring adequate hydration
• Treating any underlying infections or medical conditions
• Gradually increasing the volume of F-75 as tolerated

Also see

• Severe acute malnutrition
• Refeeding syndrome
• F-100
• Therapeutic feeding

References

• World Health Organization. "Management of severe malnutrition: a manual for physicians and other senior health workers." Geneva: WHO, 1999.
• Golden, M. H. "Proposed recommended nutrient densities for moderately malnourished children." Food and Nutrition Bulletin, 2009.

Nutrition information of FA2H

• USDA on FA2H